SCHEMBL3728243

SCHEMBL3728243

CCN1C=C(C(N)=O)C=CC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.31
DPP8 Q6V1X1 2/20 0.31
DPP9 Q86TI2 1/20 0.31
DPP7 Q9UHL4 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8855845 0.86 LMNA (0.32)
SCHEMBL1716732 0.82
SCHEMBL3509200 0.76
SCHEMBL9334241 0.73
SCHEMBL7035778 0.71
SCHEMBL29683349 0.71
SCHEMBL1715048 0.71
SCHEMBL17512746 0.69
SCHEMBL1118054 0.67
SCHEMBL19814980 0.66 PARP1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010144612-A1 COMPOSITIONS AND METHODS FOR OPTIMIZING DRUG HYDROPHOBICITY AND DRUG DELIVERY TO CELLS URRY INTELLECTUAL PROPERTY LLC (US) 2010-12-16 WO disclosed
US-5614510-A AMMONIUM SALTS PERSTORP AB (SE) 1997-03-25 US disclosed
WO-1993016705-A1 A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE PERSTORP AB (SE) 1993-09-02 WO disclosed